CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- 4 Planned sale Chairman & CEO sold 1,000 shares at an average $108.95 ($108,950)
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 101,621 shares at an average $98.34 ($9,993,082)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chairman & CEO sold 1,500 shares at an average $117.57 ($176,350)
- 144 Insider Sale of Securities
- 10-K/A Report 10-K/A
- 8-K Event Regulation FD disclosure · Other events
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- SC TO-T/A Deal Tender Offer Statement
- 8-K Event Material agreement
- SC TO-T/A Deal Tender Offer Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC TO-T/A Deal Tender Offer Statement
- 4 Planned sale Chairman & CEO sold 1,500 shares at $123.75 ($185,625)
Page 12 of 110 · 2,194 filings